adcd40l
Gene therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2006 (NCT00891748)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- CD40-CD40LSupplementation
CD40-CD40L supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- adcd40l
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01455259 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2011 | Uppsala University |
| NCT00891748 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2006 | Uppsala University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Uppsala University | Academic/Hospital | 2 | 2 | 1 | 2006 |
1 organizations
Page 1 / 1